Mechanism of action of emergency contraception

References

1. Guttmacher Institute. www.guttmacher.org.

   View in Article

   • Google Scholar
2. • Henshaw S.K.
   • Singh S.
   • Haas T.
   The incidence of abortion worldwide.
   Int Fam Plan Perspect. 1999; 25: 30-38
   View in Article

   • Google Scholar
3. Consensus statement of emergency contraception. Consortium for Emergency Contraception.
   Contraception. 1995; 52: 211-213
   View in Article

   • Google Scholar
4. • Trussell J.
   • Ellertson C.
   • von Hertzen H.
   • et al.
   Estimating the effectiveness of emergency contraceptive pills.
   Contraception. 2003; 67: 259-265
   View in Article

   • Google Scholar
5. • Gemzell-Danielsson K.
   • Marions L.
   Mechanisms of action of mifepristone and levonorgestrel when used for emergency contraception.
   Hum Reprod. 2004; 10: 341-348
   View in Article

   • Google Scholar
6. • Thomasen A.L.
   ���Historia animalium��� compared to ���Gynaecia��� in the literature of the Middle Ages.
   Clio Med. 1980; 15 (German): 5-24
   View in Article

   • Google Scholar
7. • Morris J.M.
   • van Wagenen G.
   Compounds interfering with ovum implantation and development. III. The role of estrogens.
   Am J Obstet Gynecol. 1966; 96: 804-813
   View in Article

   • Google Scholar
8. • Yuzpe A.A.
   • Lance W.J.
   Ethinylestradiol and dl-norgestrel as a potential contraceptive.
   Fertile Steril. 1977; 28: 932-936
   View in Article

   • Google Scholar
9. • Glasier A.
   • Thong K.J.
   • Dewar M.
   • Mackie M.
   • Baird D.
   Mifepristone (RU 486) compared with high-dose estrogen and progesterone for emergency postcoital contraception.
   N Engl J Med. 1992; 327: 1041-1044
   View in Article

   • Google Scholar
10. • Webb A.M.
    • Russell J.
    • Elstein M.
    Comparison of Yuzpe regimen, danazol and mifepristone (RU486) in oral postcoital contraception.
    Br Med J. 1992; 305: 927-931
    View in Article

    • Google Scholar
11. • Lippes J.
    • Tatum H.J.
    • Maulik D.
    • Sielezny M.
    Postcoital copper IUDs.
    Adv Plan Parent. 1979; 14: 87-94
    View in Article

    • Google Scholar
12. • World Health Organization
    Task Force on Post-ovulatory Methods for Fertility Regulation. Randomized controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception.
    Lancet. 1998; 352: 428-433
    View in Article

    • Google Scholar
13. • World Health Organization Task Force on Post-ovulatory Methods for Fertility Regulation
    Comparison of three single doses of mifepristone as emergency contraception: a randomised trial.
    Lancet. 1999; 353: 697-702
    View in Article

    • Google Scholar
14. • Cheng L.
    • Gulmezoglu A.M.
    • Piaggio G.
    • Ezcurra E.
    • Van Look P.F.
    Interventions for emergency contraception.
    Cochrane Database Syst Rev. 2008; : CD001324
    View in Article

    • Google Scholar
15. • von Hertzen H.
    • Piaggio G.
    • Ding J.
    • et al.
    Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicentre randomised trial.
    Lancet. 2002; 360: 1803-1810
    View in Article

    • Google Scholar
16. • Hamoda H.
    • Ashok P.W.
    • Stalder C.
    • Flett G.M.
    • Kennedy E.
    • Templeton A.
    A randomized trial of mifepristone (10 mg) and levonorgestrel for emergency contraception.
    Obstet Gynecol. 2004; 104: 1307-1313
    View in Article

    • Google Scholar
17. • Creinin M.D.
    • Schlaff W.
    • Archer D.F.
    • et al.
    Progesterone receptor modulator for emergency contraception. A randomized controlled trial.
    Obstet Gynecol. 2006; 108: 1089-1097
    View in Article

    • Google Scholar
18. • Blithe D.L.
    • Nieman L.K.
    • Blye R.P.
    • Stratton P.
    • Passaro M.
    Development of the selective progesterone receptor modulator CDB-2914 for clinical indications.
    Steroids. 2003; 68: 1013-1017
    View in Article

    • Google Scholar
19. • Wilcox A.J.
    • Weinberg C.R.
    • Baird D.D.
    Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby.
    N Engl J Med. 1995; 333: 1517-1521
    View in Article

    • Google Scholar
20. • M��ller A.L.
    • Llados C.M.
    • Croxatto H.B.
    Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat.
    Contraception. 2003; 67: 415-419
    View in Article

    • Google Scholar
21. • Novikova N.
    • Weisberg E.
    • Stanczyk F.Z.
    • Croxatto H.B.
    • Fraser I.S.
    Effectiveness of levonorgestrel emergency contraception given before or after ovulation ��� a pilot study.
    Contraception. 2007; 75: 112-118
    View in Article

    • Google Scholar
22. • Wilcox A.J.
    • Baird D.D.
    • Dunson D.B.
    • McConnaughey D.R.
    • Kesner J.S.
    • Weinberg C.R.
    On the frequency of intercourse around ovulation: evidence for biological influences.
    Hum Reprod. 2004; 19: 1539-1543
    View in Article

    • Google Scholar
23. • Bahamondes L.
    • Nascimento J.A.A.
    • Munuce M.J.
    • Fazano F.
    • Faundes A.
    The in vitro effect of levonorgestrel on the acrosome reaction of human spermatozoa from fertile men.
    Contraception. 2003; 68: 55-59
    View in Article

    • Google Scholar
24. • Yeung W.S.B.
    • Chiu P.C.N.
    • Wang C.H.Y.Q.
    • Yao Y.Q.
    • Ho P.C.
    The effects of levonorgestrel on various sperm functions.
    Contraception. 2002; 66: 453-457
    View in Article

    • Google Scholar

25. Kesser�� E. Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska Institutet/ Karolinska University Hospital, S-171 76 �� E,

    View in Article

    • Google Scholar
26. • Kesser�� E.
    • Garmendia F.
    • Westphal N.
    • Parada J.
    The hormonal and peripheral effects of dl-norgestrel in postcoital contraception.
    Contraception. 1974; 10: 411-424
    View in Article

    • Google Scholar
27. • Kunz G.
    • Beil D.
    • Deininger H.
    • Wildt L.
    • Leyendecker G.
    The dynamics of rapid sperm transport through the female genital tract: evidence from vaginal sonography of uterine peristalsis and hystero-salpingoscintigraphy.
    Hum Reprod. 1996; 11: 627-632
    View in Article

    • Google Scholar
28. • do Nascimento J.A.
    • Seppala M.
    • Perdigao A.
    • et al.
    In vivo assessment of the human sperm acrosome reaction and the expression of glycodelin-A in human endometrium after levonorgestrel-emergency contraceptive pill administration.
    Hum Reprod. 2007; 22: 2190-2195
    View in Article

    • Google Scholar
29. • Marions L.
    • Hultenby K.
    • Lindell I.
    • Sun X.
    • Stabi B.
    Gemzell Danielsson K Emergency contraception with mifepristone and levonorgestrel: mechanism of action.
    Obstet Gynecol. 2002; 100: 65-71
    View in Article

    • Google Scholar
30. • Marions L.
    • Cekan C.
    • Bygdeman M.
    • Gemzell Danielsson K.
    Preovulatory treatment with mifepristone and levonorgestrel impairs luteal function.
    Contraception. 2004; 69: 373-377
    View in Article

    • Google Scholar
31. • Hapangama D.K.
    • Glasier A.F.
    • Baird D.T.
    The effects of peri-ovulatory administration of levonorgestrel on the menstrual cycle.
    Contraception. 2001; 63: 123-129
    View in Article

    • Google Scholar
32. • Croxatto H.B.
    • Brache V.
    • Pavez M.
    • et al.
    Pituitary-ovarian function following the standard levonorgestrel emergency contraceptive dose or a single 0.75-mg dose given on the days preceding ovulation.
    Contraception. 2004; 70: 442-450
    View in Article

    • Google Scholar
33. • Spitz I.M.
    • Croxatto H.B.
    • Salvatierra A.M.
    • Heikinheimo O.
    Response to intermittent RU486 in women.
    Fertil Steril. 1993; 59: 971-975
    View in Article

    • Google Scholar
34. • Liu J.H.
    • Garzo G.
    • Morris S.
    • Stuenkel C.
    • Ulmann A.
    • Yen S.S.
    Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    J Clin Endocrinol Metab. 1987; 65: 1135-1140
    View in Article

    • Google Scholar
35. • Shoupe D.
    • Mishell Jr, D.R.
    • Page M.A.
    • Madkour H.
    • Spitz I.M.
    • Lobo R.A.
    Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.
    Am J Obstet Gynecol. 1987; 157: 1421-1426
    View in Article

    • Google Scholar
36. • Swahn M.L.
    • Johannisson E.
    • Daniore V.
    • de la Torre B.
    • Bygdeman M.
    The effect of RU 486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium.
    Hum Reprod. 1988; 3: 915-921
    View in Article

    • Google Scholar
37. • Ghosh D.
    • Kumar P.G.
    • Sengupta J.
    Early luteal phase administration of mifepristone inhibits preimplantation embryo development and viability in the rhesus monkey.
    Hum Reprod. 1997; 12: 575-582
    View in Article

    • Google Scholar
38. • Batista M.C.
    • Cartledge T.P.
    • Zellmer A.W.
    • Nieman L.K.
    • Merriam G.R.
    • Loriaux D.L.
    Evidence for a critical role of progesterone in the regulation of the midcycle gonadotropin surge and ovulation.
    J Clin Endocrinol Metab. 1992; 74: 565-570
    View in Article

    • Google Scholar
39. • Batista M.C.
    • Cartledge T.P.
    • Zellmer A.W.
    • Nieman L.K.
    • Loriaux D.L.
    • Merriam G.R.
    The antiprogestin RU 486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles.
    Fertil Steril. 1994; 62: 28-34
    View in Article

    • Google Scholar
40. • Smotrich D.B.
    • Stillman R.J.
    • Widra E.A.
    • et al.
    Immunocytochemical localization of growth factors and their receptors in the human pre-embryos and Fallopian tubes.
    Hum Reprod. 1996; 11: 184-190
    View in Article

    • Google Scholar
41. • Christow A.
    • Sun X.
    • Gemzell-Danielsson K.
    Effect of mifepristone and levonorgestrel on expression of steroid receptors in the human Fallopian tube.
    Mol Hum Reprod. 2002; 8: 333-340
    View in Article

    • Google Scholar
42. • Mahmood T.
    • Saridogan E.
    • Smutna S.
    • Habib A.M.
    • Djahanbakhch O.
    The effect of ovarian steroids on epithelial ciliary beat frequency in the human Fallopian tube.
    Hum Reprod. 1998; 13: 2991-2994
    View in Article

    • Google Scholar
43. • Psychoyos A.
    • Prapas I.
    Inhibition of egg development and implantation in rats after post-coital administration of the progesterone antagonist RU 486.
    J Reprod Fertil. 1987; 80: 487-491
    View in Article

    • Google Scholar
44. • Wolf J.P.
    • Danforth D.R.
    • Ulmann A.
    • Baulieu E.E.
    • Hodgen G.D.
    Contraceptive potential of RU486 by ovulation inhibition II. Suppression of pituitary gonadotropin secretion in vitro.
    Contraception. 1989; 40: 185-193
    View in Article

    • Google Scholar
45. • Messinis I.E.
    • Templeton A.
    The effect of the antiprogestin mifepristone (RU486) on maturation and in-vitro fertilization of human oocytes.
    Br J Obstet Gynaecol. 1998; 95: 592-595
    View in Article

    • Google Scholar
46. • Durand M.
    • del Carmen Cravioto M.
    • Raymond E.G.
    • et al.
    The mechanism of action of short-term levonorgestrel administration in emergency contraception.
    Contraception. 2001; 64: 227-234
    View in Article

    • Google Scholar
47. • Swahn M.L.
    • Gemzell K.
    • Bygdeman M.
    Contraception with mifepristone.
    Letter to the Editor, Lancet. 1991; 338: 942-943
    View in Article

    • Google Scholar
48. • Gemzell Danielsson K.
    • Swahn M.L.
    • Svalander P.
    • Bygdeman M.
    Early luteal phase treatment with RU486 for fertility regulation.
    Hum Reprod. 1993; 8: 870-873
    View in Article

    • Google Scholar
49. • Gemzell Danielsson K.
    • Svalander P.
    • Swahn M.L.
    • Johannisson E.
    • Bygdeman M.
    Effects of a single-postovulatory dose of RU486 on endometrial maturation in the implantation phase.
    Hum Reprod. 1994; 9: 2398-2404
    View in Article

    • Google Scholar
50. • Hapangama D.K.
    • Brown A.
    • Glasier A.F.
    • Baird D.T.
    Feasibility of administering mifepristone as a once a month contraceptive pill.
    Hum Reprod. 2001; 16: 1145-1150
    View in Article

    • Google Scholar
51. • Gemzell-Danielsson K.
    • Swahn M.
    • Bygdeman M.
    The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase���an immunohistochemical study.
    Hum Reprod. 1997; 12: 1293-1297
    View in Article

    • Google Scholar
52. • Marions L.
    • Gemzell Danielsson K.
    • Swahn M.
    • Bygdeman M.
    The effect of antiprogestin on integrin expression in human endometrium: an immunohistochemical study.
    Hum Reprod. 1998; 4: 491-495
    View in Article

    • Google Scholar
53. • Slayden O.D.
    • Nayak N.R.
    • Burton K.A.
    • et al.
    Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium.
    J Clin Endocrinol Metab. 2001; 86: 2668-2679
    View in Article

    • Google Scholar
54. • Cameron S.T.
    • Critchley H.O.
    • Buckley C.H.
    • Kelly R.W.
    • Baird D.T.
    Effect of two antiprogestins (mifepristone and onapristone) on endometrial factors of potential importance for implantation.
    Fertil Steril. 1997; 67: 1046-1053
    View in Article

    • Google Scholar
55. • Gemzell Danielsson K.
    • Hamberg M.
    The effect of antiprogestin (RU 486) and prostaglandin biosynthesis inhibitor (naproxen) on uterine fluid prostaglandin F2_a concentration.
    Hum Reprod. 1994; 9: 1626-1630
    View in Article

    • Google Scholar
56. • Swahn M.L.
    • Bygdeman M.
    • Xing S.
    • Cekan S.
    • Masironi B.
    • Johannisson E.
    The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Hum Reprod. 1990; 5: 402-408
    View in Article

    • Google Scholar
57. • Gemzell Danielsson K.
    • Westlund P.
    • Swahn M.L.
    • Bygdeman M.
    • Seppala M.
    Effect of low weekly doses of mifepristone on ovarian function and endometrial development.
    Hum Reprod. 1996; 11: 256-264
    View in Article

    • Google Scholar
58. • Gemzell Danielsson K.
    • Swahn M.L.
    • Westlund P.
    • Johannisson E.
    • Sepp��l�� M.
    • Bygdeman M.
    Effect of low daily doses of mifepristone on ovarian function and endometrial development.
    Hum Reprod. 1997; 12: 124-131
    View in Article

    • Google Scholar
59. • Marions L.
    • Gemzell Danielsson K.
    • Swahn M.L.
    • Bygdeman M.
    Contraceptive efficacy of low doses of mifepristone.
    Fertil Steril. 1998; 70: 813-816
    View in Article

    • Google Scholar
60. • Marions L.
    • Viski S.
    • Danielsson K.G.
    • et al.
    Contraceptive efficacy of daily administration of 0.5 mg mifepristone.
    Hum Reprod. 1999; 14: 2788-2790
    View in Article

    • Google Scholar
61. • Godfrey E.M.
    • Mawson J.T.
    • Stanwood N.L.
    • Fielding S.L.
    • Schaff E.A.
    Low-dose mifepristone for contraception: a weekly versus planned postcoital randomized pilot study.
    Contraception. 2004; 70: 41-46
    View in Article

    • Google Scholar
62. • Lalitkumar P.G.L.
    • Lalitkumar S.
    • Meng C.X.
    • et al.
    Mifepristone but not levonorgestrel inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model.
    Hum Reprod. 2007; 22: 3031-3037
    View in Article

    • Google Scholar
63. • Meng C.X.
    • Andersson K.
    • Benten-Ley U.
    • Gemzell-Danielsson K.
    • Lalitkumar P.G.
    Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
    Fertil Steril. 2008; : 16
    View in Article

    • Google Scholar
64. • Zhang L.
    • Chen J.
    • Wang Y.
    • Ren F.
    • Yu W.
    • Cheng L.
    Pregnancy outcome after levonorgestrel-only emergency contraception failure: a prospective cohort study.
    Hum Reprod. 2009; 24: 1605-1611
    View in Article

    • Google Scholar

65. Croxatto HB, Brahe V, Cochon L, et al. The effects of Immediate pre-ovulatory administration of 30 mg Ulipristal acetate on follicular rupture. Abstract, Rome ESG Sept 10-14, 2009.

    View in Article

    • Google Scholar
66. • Stratton P.
    • Hartog B.
    • Hajizadeh N.
    • et al.
    Endometrial effects of a single early-luteal dose of the selective progesterone receptor modulator CDB-2914.
    Hum Reprod. 2000; 15: 1092-1099
    View in Article

    • Google Scholar